Status:
UNKNOWN
Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
Acne vulgaris is a chronic skin disease of the pilosebaceous unit characterized by formation of papules, pustules, comedones, nodules and cysts. It can have a major psychological burden on the patient...
Detailed Description
In 2015, acne was estimated to affect 633 million people globally, making it the 8th most common disease worldwide. Acne commonly occurs in adolescence and affects an estimated 80-90% of teenagers. Ch...
Eligibility Criteria
Inclusion
- Patients with Acne of any grade.
- Patients between 18 and 45 years old.
Exclusion
- Patients below 18 and above 45years.
- Patients with any concomitant Dermatologic or systemic illness
- Patients on any topical or systemic medication within 4 weeks before enrollment.
- Pregnancy.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03866447
Start Date
October 1 2019
End Date
March 1 2021
Last Update
March 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.